Macquarie Starts CVS Health (CVS) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Cowen Raises Price Target on CVS Health (CVS) Following Investor Meetings
June 11, 2015 6:49 AM EDTCowen reiterates an Outperform rating on CVS Health (NYSE: CVS), and raised the price target to $116.00 (from $108.00), following investor meetings with management. Analyst Charles Rhyee says that the addition of OCR allows CVS to provide pharmacy services across the continuum of care.... More
